Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:03 UTC |
---|
HMDB ID | HMDB0015631 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Alvimopan |
---|
Description | Alvimopan, also known as entereg, belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Alvimopan is a drug which is used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. also investigated for use in the treatment of pain (acute or chronic). Alvimopan is a very strong basic compound (based on its pKa). In humans, alvimopan is involved in alvimopan action pathway. Alvimopan is indicated in people to avoid postoperative ileus following partial large or small bowel resection with primary anastomosis. Unlike methylnaltrexone (another peripherally acting μ-receptor antagonist) that bears a quaternary amine, alvimopan owes its selectivity for peripheral receptors to its kinetics. Gut metabolism produces an active metabolite with no clinically significant contribution to drug effect. Therefore, no interactions are expected with hepatically metabolized drugs. Alvimopan is substrate for P-glycoprotein. |
---|
Structure | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1 InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1 |
---|
Synonyms | Value | Source |
---|
ADL 8-2698Entereg | HMDB | ADL 8-2698 | HMDB | Anhydrous alvimopan | HMDB | trans-3,4-Dimethyl-4-(3-hydroxyphenyl) piperidine | HMDB | Entereg | HMDB | Alvimopan anhydrous | HMDB |
|
---|
Chemical Formula | C25H32N2O4 |
---|
Average Molecular Weight | 424.5326 |
---|
Monoisotopic Molecular Weight | 424.236207522 |
---|
IUPAC Name | 2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid |
---|
Traditional Name | alvimopan |
---|
CAS Registry Number | 156053-89-3 |
---|
SMILES | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1 |
---|
InChI Identifier | InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1 |
---|
InChI Key | UPNUIXSCZBYVBB-JVFUWBCBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Peptidomimetics |
---|
Sub Class | Hybrid peptides |
---|
Direct Parent | Hybrid peptides |
---|
Alternative Parents | |
---|
Substituents | - Hybrid peptide
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Phenylpiperidine
- Beta amino acid or derivatives
- Alpha-amino acid or derivatives
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- Monocyclic benzene moiety
- Benzenoid
- Piperidine
- Fatty acyl
- Fatty amide
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Carboxamide group
- Amino acid
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organic oxygen compound
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0083 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Alvimopan,1TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3447.0 | Semi standard non polar | 33892256 | Alvimopan,1TMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3494.3 | Semi standard non polar | 33892256 | Alvimopan,1TMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3421.5 | Semi standard non polar | 33892256 | Alvimopan,2TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3422.5 | Semi standard non polar | 33892256 | Alvimopan,2TMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3366.7 | Semi standard non polar | 33892256 | Alvimopan,2TMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3411.5 | Semi standard non polar | 33892256 | Alvimopan,3TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3389.0 | Semi standard non polar | 33892256 | Alvimopan,3TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3350.7 | Standard non polar | 33892256 | Alvimopan,3TMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C1 | 3829.7 | Standard polar | 33892256 | Alvimopan,1TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3698.6 | Semi standard non polar | 33892256 | Alvimopan,1TBDMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3732.9 | Semi standard non polar | 33892256 | Alvimopan,1TBDMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3706.2 | Semi standard non polar | 33892256 | Alvimopan,2TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3852.6 | Semi standard non polar | 33892256 | Alvimopan,2TBDMS,isomer #2 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C1 | 3853.8 | Semi standard non polar | 33892256 | Alvimopan,2TBDMS,isomer #3 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3908.4 | Semi standard non polar | 33892256 | Alvimopan,3TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 4055.7 | Semi standard non polar | 33892256 | Alvimopan,3TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 3945.1 | Standard non polar | 33892256 | Alvimopan,3TBDMS,isomer #1 | C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 4020.4 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fr6-5947300000-a56d3fba4a79398cd53e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (2 TMS) - 70eV, Positive | splash10-0fkc-9030260000-07291dc02727a1b76e9c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Positive-QTOF | splash10-00b9-4135900000-cdd9dcd5c0e44a4d2c3a | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Positive-QTOF | splash10-00di-7659100000-c6c4baaf84ffc4a524ff | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Positive-QTOF | splash10-01ba-4921000000-1d5e9cec550e68fc676d | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Negative-QTOF | splash10-00di-0013900000-26c80cc1229d409f18b0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Negative-QTOF | splash10-0fk9-2389700000-5887ae4c83be056c9be4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Negative-QTOF | splash10-0udi-7690000000-04222ab40d4c3cdf96dd | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Positive-QTOF | splash10-004i-0116900000-7e677f87932e437c28b8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Positive-QTOF | splash10-056r-0179500000-9a36c62b4f259dfc6d00 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Positive-QTOF | splash10-014i-1921000000-c9da581bb4acc528324a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 10V, Negative-QTOF | splash10-00fr-0009800000-6c5de1cc3dd55967c60b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 20V, Negative-QTOF | splash10-00fr-4509100000-844a82b338df3daf6e8e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alvimopan 40V, Negative-QTOF | splash10-01b9-7975000000-248c5b20b32a461b463d | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB06274 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB06274 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB06274 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4589864 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Alvimopan |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5488548 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 535293 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - [No authors listed] [PubMed:18373729 ]
- Wang S, Shah N, Philip J, Caraccio T, Feuerman M, Malone B: Role of alvimopan (entereg) in gastrointestinal recovery and hospital length of stay after bowel resection. P T. 2012 Sep;37(9):518-25. [PubMed:23066346 ]
- FDA [Link]
|
---|